The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Small-cell lung cancer: what we know, what we need to know and the path forward
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Sequist, L. V., Waltman, B. A., Dias-Santagata, D., Digumarthy, S., Turke, A. B., Fidias, P., Bergethon, K., Shaw, A. T., Gettinger, S., Cosper, A. K., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002003 · Cited by 3,499
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
Torre, L. A., Siegel, R. L., & Jemal, A. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-24223-1_1 · Cited by 1,903
Govindan, R., Page, N., Morgensztern, D., Read, W., Tierney, R., Vlahiotis, A., Spitznagel, E. L., & Piccirillo, J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4859 · Cited by 1,845
WHO classification of tumours of the lung, pleura, thymus and heart
Travis, W. D. (2015) · International Agency for Research on Cancer eBooks · Cited by 1,664
Kim, K. H., & Roberts, C. W. M. (2016) · Nature Medicine · doi:10.1038/nm.4036 · Cited by 1,471
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Peifer, M., Fernández-Cuesta, L., Sos, M. L., George, J., Seidel, D., Kasper, L. H., Plenker, D., Leenders, F., Sun, R., Zander, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.2396 · Cited by 1,397
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
Cuttitta, F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A., & Minna, J. D. (1985) · Nature · doi:10.1038/316823a0 · Cited by 1,349
Self-citationTargeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
p53: A Frequent Target for Genetic Abnormalities in Lung Cancer
Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., & Minna, J. D. (1989) · Science · doi:10.1126/science.2554494 · Cited by 1,197
Self-citationAn APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Roberts, S. A., Lawrence, M. S., Klimczak, L. J., Grimm, S. A., Fargo, D., Stojanov, P., Kiezun, A., Kryukov, G. V., Carter, S. L., Saksena, G., et al. (2013) · Nature Genetics · doi:10.1038/ng.2702 · Cited by 1,167
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Govindan, R., Ding, L., Griffith, M., Subramanian, J., Dees, N. D., Kanchi, K. L., Maher, C. A., Fulton, R., Fulton, L., Wallis, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.024 · Cited by 1,146
Targeting the cancer epigenome for therapy
Jones, P. A., Issa, J.-P. J., & Baylin, S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.93 · Cited by 1,128
Mutational signatures associated with tobacco smoking in human cancer
Alexandrov, L. B., Ju, Y. S., Haase, K., Van Loo, P., Martincorena, I., Nik-Zainal, S., Totoki, Y., Fujimoto, A., Nakagawa, H., Shibata, T., et al. (2016) · Science · doi:10.1126/science.aag0299 · Cited by 1,100
Rudin, C. M., Durinck, S., Stawiski, E. W., Poirier, J. T., Modrusan, Z., Shames, D. S., Bergbower, E. A., Guan, Y., Shin, J., Guillory, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2405 · Cited by 1,077
Self-citationA small-cell lung cancer genome with complex signatures of tobacco exposure
Pleasance, E. D., Stephens, P. J., O’Meara, S., McBride, D. J., Meynert, A., Jones, D., Lin, M.-L., Beare, D., Lau, K. W., Greenman, C., et al. (2010) · Nature · doi:10.1038/nature08629 · Cited by 1,066
Self-citationDammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
Little, C. D., Nau, M. M., Carney, D. N., Gazdar, A. F., & Minna, J. D. (1983) · Nature · doi:10.1038/306194a0 · Cited by 920
Self-citationAbnormalities in Structure and Expression of the Human Retinoblastoma Gene in SCLC
Harbour, J. W., Lai, S.-L., Whang-Peng, J., Gazdar, A. F., Minna, J. D., & Kaye, F. J. (1988) · Science · doi:10.1126/science.2838909 · Cited by 902
Self-citation(1986) · Lung Cancer · doi:10.1016/s0169-5002(86)80023-x · Cited by 900
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Simon, J. A., & Lange, C. A. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.07.010 · Cited by 855
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
Self-citationDurkin, S. G., & Glover, T. W. (2007) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.042007.165900 · Cited by 711
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer
Nau, M. M., Brooks, B. J., Battey, J., Sausville, E., Gazdar, A. F., Kirsch, I. R., McBride, O. W., Bertness, V., Hollis, G. F., & Minna, J. D. (1985) · Nature · doi:10.1038/318069a0 · Cited by 665
Self-citationRB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Niederst, M. J., Sequist, L. V., Poirier, J. T., Mermel, C. H., Lockerman, E. L., Garcia, A. R., Katayama, R., Costa, C., Ross, K. N., Moran, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms7377 · Cited by 647
Meuwissen, R., Linn, S. C., Linnoila, R. I., Zevenhoven, J., Mooi, W. J., & Berns, A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00220-4 · Cited by 643
Mishima, S., Nozaki, Y., Mikami, S., Kihira, E., Iikura, M., Koketsu, R., Sugiyama, H., Masuda, T., Kaname, H., Egami, Y., et al. (2015) · Case Reports in Gastroenterology · doi:10.1159/000381140 · Cited by 631
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins
Ramirez, R. D., Sheridan, S., Girard, L., Sato, M., Kim, Y., Pollack, J., Peyton, M., Zou, Y., Kurie, J. M., DiMaio, J. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3703 · Cited by 607
Self-citationSaunders, L. R., Bankovich, A. J., Anderson, W. C., Aujay, M. A., Bheddah, S., Black, K., Desai, R., Escarpe, P. A., Hampl, J., Laysang, A., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9459 · Cited by 600
Mollaoglu, G., Guthrie, M. R., Böhm, S., Brägelmann, J., Can, I., Ballieu, P. M., Marx, A., George, J., Heinen, C., Chalishazar, M. D., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.12.005 · Cited by 588
Self-citationRudin, C. M., Pietanza, M. C., Bauer, T. M., Ready, N., Morgensztern, D., Glisson, B. S., Byers, L. A., Johnson, M. L., Burris, H. A., Robert, F., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30565-4 · Cited by 574
Pearse, A. G. E. (1968) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1968.0025 · Cited by 560
Byers, L. A., Wang, J., Nilsson, M. B., Fujimoto, J., Saintigny, P., Yordy, J., Giri, U., Peyton, M., Fan, Y. H., Diao, L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0112 · Cited by 557
Self-citationShepherd, F. A., Crowley, J., Van Houtte, P., Postmus, P. E., Carney, D., Chansky, K., Shaikh, Z., & Goldstraw, P. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31815bdc0d · Cited by 548
Lerman, M. I., & Minna, J. D. (2000) · PubMed · Cited by 538
Self-citationSutherland, K. D., Proost, N., Brouns, I., Adriaensen, D., Song, J.-Y., & Berns, A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.019 · Cited by 534
Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis
Gardner, E. E., Lok, B. H., Schneeberger, V. E., Desmeules, P., Miles, L. A., Arnold, P. K., Ni, A., Khodos, I., de Stanchina, E., Nguyen, T., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.006 · Cited by 526
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
Mohammad, H. P., Smitheman, K. N., Kamat, C. D., Soong, D., Federowicz, K. E., Van Aller, G. S., Schneck, J. L., Carson, J. D., Liu, Y., Butticello, M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.06.002 · Cited by 504
Borromeo, M. D., Savage, T. K., Kollipara, R. K., He, M., Augustyn, A., Osborne, J. K., Girard, L., Minna, J. D., Gazdar, A. F., Cobb, M. H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.081 · Cited by 503
Self-citationRekhtman, N., Pietanza, M. C., Hellmann, M. D., Naidoo, J., Arora, A., Won, H., Halpenny, D. F., Wang, H., Tian, S. K., Litvak, A. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2946 · Cited by 487
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
Lim, J. S., Ibaseta, A., Fischer, M. M., Cancilla, B., O’Young, G., Cristea, S., Luca, V. C., Yang, D., Jahchan, N. S., Hamard, C., et al. (2017) · Nature · doi:10.1038/nature22323 · Cited by 485
Keynote address on biostatistics and data retrieval.
Zelen, M. (1973) · PubMed · Cited by 482
Gazdar, A. F., Carney, D. N., Nau, M. M., & Minna, J. D. (1985) · PubMed · Cited by 477
Self-citationAn achaete-scute homologue essential for neuroendocrine differentiation in the lung
Borges, M., Linnoila, R. I., van de Velde, H. J. K., Chen, H., Nelkin, B. D., Mabry, M., Baylin, S. B., & Ball, D. W. (1997) · Nature · doi:10.1038/386852a0 · Cited by 454
Specific Chromosome Defect Associated with Human Small-Cell Lung Cancer: Deletion 3p(14-23)
Whang-Peng, J., Kao-Shan, C. S., Lee, E. C., Bunn, P. A., Carney, D. N., Gazdar, A. F., & Minna, J. D. (1982) · Science · doi:10.1126/science.6274023 · Cited by 452
Self-citationCD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
Weiskopf, K., Jahchan, N. S., Schnorr, P. J., Cristea, S., Ring, A. M., Maute, R. L., Volkmer, A. K., Volkmer, J.-P., Liu, J., Lim, J. S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81603 · Cited by 444
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Christensen, C. L., Kwiatkowski, N., Abraham, B. J., Carretero, J., Al-Shahrour, F., Zhang, T., Chipumuro, E., Herter-Sprie, G. S., Akbay, E. A., Altabef, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.019 · Cited by 439
Lambert–Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies
Titulaer, M. J., Lang, B., & Verschuuren, J. J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70245-9 · Cited by 408
Wistuba, I. I., Behrens, C., Virmani, A. K., Mele, G. M., Milchgrub, S., Girard, L., Fondon, J. W., Garner, H. R., McKay, B., Latif, F., et al. (2000) · PubMed · Cited by 405
Self-citationSox2, a key factor in the regulation of pluripotency and neural differentiation
Zhang, S. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i3.305 · Cited by 397
Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers
Zabarovsky, E. R., Lerman, M. I., & Minna, J. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205835 · Cited by 382
Self-citationAgathanggelou, A., Honorio, S., Macartney, D. P., Martinez, A., Dallol, A., Rader, J., Fullwood, P., Chauhan, A., Walker, R., Shaw, J. A., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204175 · Cited by 376
Self-citationFrom Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
Ntziachristos, P., Lim, J. S., Sage, J., & Aifantis, I. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.018 · Cited by 374
A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer
Calbo, J., van Montfort, E., Proost, N., van Drunen, E., Beverloo, H. B., Meuwissen, R., & Berns, A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.021 · Cited by 369
Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility
Denny, S. K., Yang, D., Chuang, C.-H., Brady, J. J., Lim, J. S., Grüner, B. M., Chiou, S.-H., Schep, A. N., Baral, J., Hamard, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.052 · Cited by 368
Rudin, C. M., Ismaila, N., Hann, C. L., Malhotra, N., Movsas, B., Norris, K., Pietanza, M. C., Ramalingam, S. S., Turrisi, A. T., & Giaccone, G. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.7918 · Cited by 350
Gazdar, A. F., Carney, D. N., RUSSELL, E. K., Sims, H. L., Baylin, S. B., Bunn, P. A., Guccion, J. G., & Minna, J. D. (1980) · PubMed · Cited by 316
Self-citationCarter, L., Rothwell, D. G., Mesquita, B., Smowton, C., Leong, H. S., Fernandez-Gutierrez, F., Li, Y., Burt, D. J., Antonello, J., Morrow, C. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4239 · Cited by 308
NCI-navy medical oncology branch cell line data base
Phelps, R. M., Johnson, B. E., Ihde, D. C., Gazdar, A. F., Carbone, D. P., McClintock, P. R., Linnoila, R. I., Matthews, M. J., Bunn, P. A., Carney, D., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630505 · Cited by 303
Self-citationMouse models for human lung cancer
Meuwissen, R., & Berns, A. (2005) · Genes & Development · doi:10.1101/gad.1284505 · Cited by 302
Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
Murai, J., Feng, Y., Yu, G. K., Ru, Y., Tang, S.-W., Shen, Y., & Pommier, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12266 · Cited by 297
One mouse, one patient paradigm: New avatars of personalized cancer therapy
Malaney, P., Nicosia, S. V., & Davé, V. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.10.010 · Cited by 289
Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing
McFadden, D. G., Papagiannakopoulos, T., Taylor-Weiner, A., Stewart, C., Carter, S. L., Cibulskis, K., Bhutkar, A., McKenna, A., Dooley, A., Vernon, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.02.031 · Cited by 288
Carney, D. N., Mitchell, J. B., & Kinsella, T. J. (1983) · PubMed · Cited by 287
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
Augustyn, A., Borromeo, M., Wang, T., Fujimoto, J., Shao, C., Dospoy, P. D., Lee, V., Tan, C., Sullivan, J. P., Larsen, J. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410419111 · Cited by 282
Self-citationEctopic ACTH Production in Carcinoma of the Lung
Gewirtz, G., & Yalow, R. S. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107639 · Cited by 269
US lung cancer trends by histologic type
Lewis, D. R., Check, D. P., Caporaso, N. E., Travis, W. D., & Devesa, S. S. (2014) · Cancer · doi:10.1002/cncr.28749 · Cited by 264
Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma
Schaffer, B. E., Park, K.-S., Yiu, G., Conklin, J. F., Lin, C., Burkhart, D. L., Karnezis, A. N., Sweet-Cordero, E. A., & Sage, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4228 · Cited by 253
Origins, genetic landscape, and emerging therapies of small cell lung cancer
Semenova, E. A., Nagel, R., & Berns, A. (2015) · Genes & Development · doi:10.1101/gad.263145.115 · Cited by 250
Poirier, J. T., Gardner, E. E., Connis, N., Moreira, A. L., de Stanchina, E., Hann, C. L., & Rudin, C. M. (2015) · Oncogene · doi:10.1038/onc.2015.38 · Cited by 248
Oat‐cell carcinoma of the bronchus
Azzopardi, J. G. (1959) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700780218 · Cited by 233
Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?
Pietanza, M. C., Byers, L. A., Minna, J. D., & Rudin, C. M. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2958 · Cited by 228
Self-citationKanaji, N. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i3.197 · Cited by 227
Stewart, C. A., Tong, P., Cardnell, R. J., Sen, T., Li, L., Gay, C. M., Masrorpour, F., Fan, Y., Bara, R. O., Feng, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15338 · Cited by 227
Niu, Y., Ma, F., Huang, W., Fang, S., Li, M., Wei, T., & Guo, L. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0575-6 · Cited by 226
Pathogenesis of lung cancer signalling pathways: roadmap for therapies
Brambilla, E., & Gazdar, A. (2009) · European Respiratory Journal · doi:10.1183/09031936.00014009 · Cited by 205
Self-citationHuman Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations
Sato, M., Larsen, J. E., Lee, W., Sun, H., Shames, D. S., Dalvi, M. P., Ramirez, R. D., Tang, H., DiMaio, J. M., Gao, B., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0634-t · Cited by 205
Self-citationEpigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential
Kazanets, A., Shorstova, T., Hilmi, K., Marques, M., & Witcher, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.04.001 · Cited by 195
Sen, T., Tong, P., Stewart, C. A., Cristea, S., Valliani, A., Shames, D. S., Redwood, A. B., Fan, Y. H., Li, L., Glisson, B. S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3409 · Cited by 194
Self-citationPossible roles of DLK1 in the Notch pathway during development and disease
Falix, F. A., Aronson, D. C., Lamers, W. H., & Gaemers, I. C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.003 · Cited by 191
PEARSE, A. G. E. (1966) · Nature · doi:10.1038/211598a0 · Cited by 185
Liquid biopsies in lung cancer: The new ambrosia of researchers
Rolfo, C., Castiglia, M., Hong, D., Alessandro, R., Mertens, I., Baggerman, G., Zwaenepoel, K., Gil-Bazo, I., Passiglia, F., Carreca, A. P., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.001 · Cited by 181
Bunn, P. A., Minna, J. D., Augustyn, A., Gazdar, A. F., Ouadah, Y., Krasnow, M. A., Berns, A., Brambilla, E., Rekhtman, N., Massion, P. P., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.01.012 · Cited by 181
Self-citationSwarts, D. R. A., Ramaekers, F. C. S., & Speel, E.-J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.001 · Cited by 179
A framework for identification of actionable cancer genome dependencies in small cell lung cancer
Sos, M. L., Dietlein, F., Peifer, M., Schöttle, J., Balke-Want, H., Müller, C., Koker, M., Richters, A., Heynck, S., Malchers, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207310109 · Cited by 179
Meder, L., König, K., Ozretić, L., Schultheis, A. M., Ueckeroth, F., Ade, C. P., Albus, K., Boehm, D., Rommerscheidt‐Fuss, U., Florin, A., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.29835 · Cited by 179
Sullivan, J. P., Minna, J. D., & Shay, J. W. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9216-5 · Cited by 176
Self-citationPreclinical Murine Models for Lung Cancer: Clinical Trial Applications
Kellar, A., Egan, C., & Morris, D. (2015) · BioMed Research International · doi:10.1155/2015/621324 · Cited by 169
Polley, E., Kunkel, M., Evans, D., Silvers, T., Delosh, R., Laudeman, J., Ogle, C., Reinhart, R., Selby, M., Connelly, J., et al. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw122 · Cited by 169
Romero, O. A., Torres-Diz, M., Pros, E., Savola, S., Gomez, A., Moran, S., Saez, C., Iwakawa, R., Villanueva, A., Montuenga, L. M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0799 · Cited by 165
The Schlafen Family of Proteins and Their Regulation by Interferons
Mavrommatis, E., Fish, E. N., & Platanias, L. C. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0133 · Cited by 164
The Endocrine Lung in Health and Disease
Guidotti, T. L. (1985) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1985.03350340118032 · Cited by 162
Yamaguchi, T., Hosono, Y., Yanagisawa, K., & Takahashi, T. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.002 · Cited by 159
Semenova, E. A., Kwon, M.-C., Monkhorst, K., Song, J.-Y., Bhaskaran, R., Krijgsman, O., Kuilman, T., Peters, D., Buikhuisen, W. A., Smit, E. F., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.020 · Cited by 159
Wynes, M. W., Hinz, T. K., Gao, D., Martini, M., Marek, L. A., Ware, K. E., Edwards, M. G., Böhm, D., Perner, S., Helfrich, B. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3060 · Cited by 156
Self-citationKwon, M.-C., & Berns, A. J. M. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.010 · Cited by 153
Molecular changes in the bronchial epithelium of patients with small cell lung cancer.
Wistuba, I. I., Berry, J., Behrens, C., Maitra, A., Shivapurkar, N., Milchgrub, S., Mackay, B., Minna, J. D., & Gazdar, A. F. (2000) · PubMed · Cited by 148
Self-citationSimms, E. B., Gazdar, A. F., Abrams, P. G., & Minna, J. D. (1980) · PubMed · Cited by 134
Self-citationSelective Tropism of Seneca Valley Virus for Variant Subtype Small Cell Lung Cancer
Poirier, J. T., Dobromilskaya, I., Moriarty, W. F., Peacock, C. D., Hann, C. L., & Rudin, C. M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt130 · Cited by 133
Kawahara, M., Ushijima, S., Kamimori, T., Kodama, N., Ogawara, M., Matsui, K., Masuda, N., Takada, M., Sobue, T., & Furuse, K. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.507 · Cited by 132
PTEN Is a Potent Suppressor of Small Cell Lung Cancer
Cui, M., Augert, A., Rongione, M. A., Conkrite, K. L., Parazzoli, S. D., Nikitin, A. Y., Ingolia, N. T., & MacPherson, D. P. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0554 · Cited by 131
Epidemiology of Lung Cancer in Korea: Recent Trends
Park, J. Y., & Jang, S. H. (2016) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2016.79.2.58 · Cited by 127
Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes
Singh, M., Murriel, C. L., & Johnson, L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2786 · Cited by 125
Targeting BCL2-Proteins for the Treatment of Solid Tumours
Vogler, M. (2014) · Advances in Medicine · doi:10.1155/2014/943648 · Cited by 124
Gazdar, A. F., Savage, T. K., Johnson, J. E. B., Berns, A. J. M., Sage, J., Linnoila, R. I., MacPherson, D. P., McFadden, D. G., Farago, A. F., Jacks, T., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000459 · Cited by 123
Self-citationAugert, A., Zhang, Q., Bates, B. M., Cui, M., Wang, X., Wildey, G. M., Dowlati, A., & MacPherson, D. P. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.12.011 · Cited by 121
EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway
Murai, F., Koinuma, D., Shinozaki‐Ushiku, A., Fukayama, M., Miyaozono, K., & Ehata, S. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.26 · Cited by 111
Fang, S., Gao, H.-Y., Tong, Y. A., Yang, J., Tang, R., Niu, Y., Li, M., & Guo, L. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.123 · Cited by 110
Spheroid Culture of Primary Lung Cancer Cells with Neuregulin 1/HER3 Pathway Activation
Endo, H., Okami, J., Okuyama, H., Kumagai, T., Uchida, J., Kondo, J., Takehara, T., Nishizawa, Y., Imamura, F., Higashiyama, M., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182779ccf · Cited by 109
Schultheis, A. M., Bos, M. C. A., Schmitz, K., Wilsberg, L., Binot, E., Wolf, J., Büttner, R., & Schildhaus, H. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.141 · Cited by 108
MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway
Tripathi, S. C., Fahrmann, J. F., Çeliktaş, M., Aguilar, M., Marini, K. D., Jolly, M. K., Katayama, H., Wang, H., Murage, E. N., Dennison, J. B., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2874 · Cited by 104
Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target
Wen, Y., Cai, J., Hou, Y., Huang, Z., & Wang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.16467 · Cited by 101
Kim, D. W., Wu, N., Kim, Y., Cheng, P. F., Basom, R., Kim, D., Dunn, C. T., Lee, A. Y., Kim, K., Lee, C. S., et al. (2016) · Genes & Development · doi:10.1101/gad.279307.116 · Cited by 96
Self-citationThe origin of neuroendocrine tumors and the neural crest saga
Rosaí, J. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.166 · Cited by 95
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
Cardnell, R. J., Feng, Y., Mukherjee, S., Diao, L., Tong, P., Stewart, C. A., Masrorpour, F., Fan, Y.-H., Nilsson, M. B., Shen, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152584 · Cited by 93
Kalari, S. K., Jung, M., Kernstine, K. H., Takahashi, T., & Pfeifer, G. P. (2012) · Oncogene · doi:10.1038/onc.2012.362 · Cited by 92
Cancer stem cells in small cell lung cancer.
Codony‐Servat, J., Verlicchi, A., & Rosell, R. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2016.01.01 · Cited by 92
Hubaux, R., Thu, K. L., Coe, B. P., MacAulay, C. E., Lam, S. C., & Lam, W. L. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318298762f · Cited by 88
Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation
Fiorentino, F. P., Tokgün, P. E., Solé‐Sánchez, S., Giampaolo, S., Tokgün, O., Jauset, T., Kohno, T., Perucho, M., Soucek, L., & Yokota, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8826 · Cited by 87
Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer
Jahchan, N. S., Lim, J. S., Bola, B. M., Morris, K. L., Seitz, G., Tran, K. Q. T., Xu, L., Trapani, F., Morrow, C. J., Cristea, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.021 · Cited by 83
Transcriptional control of vertebrate neurogenesis by the proneural factor Ascl1
Vasconcelos, F. F., & Castro, D. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00412 · Cited by 82
NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
Wu, N., Jia, D., Ibrahim, A. H., Bachurski, C. J., Gronostajski, R. M., & MacPherson, D. P. (2016) · Oncotarget · doi:10.18632/oncotarget.11583 · Cited by 78
The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer
Horn, L., Reck, M., & Spigel, D. R. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0523 · Cited by 76
Spigel, D. R., & Socinski, M. A. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318286cf88 · Cited by 74
Shibata, T., Kokubu, A., Tsuta, K., & Hirohashi, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.038 · Cited by 72
Cancer Therapy Due to Apoptosis: Galectin-9
Fujita, K., Iwama, H., Oura, K., Tadokoro, T., Samukawa, E., Sakamoto, T., Nomura, T., Tani, J., Yoneyama, H., Morishita, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010074 · Cited by 71
Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies.
Shekhani, M. T., Jayanthy, A., Maddodi, N., & Setaluri, V. (2013) · Europe PMC (PubMed Central) · Cited by 69
Jiang, T., Wang, Y., Zhou, F., Gao, G., Ren, S., & Zhou, C. (2015) · Oncotarget · doi:10.18632/oncotarget.6612 · Cited by 68
Shining light on novel targets and therapies
Rudin, C. M., & Poirier, J. T. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.203 · Cited by 68
Methylation of SLFN11 is a Marker of Poor Prognosis and Cisplatin Resistance in Colorectal Cancer
He, T., Zhang, M., Zheng, R., Zheng, S., Linghu, E., Herman, J. G., & Guo, M. (2017) · Epigenomics · doi:10.2217/epi-2017-0019 · Cited by 67
From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers
Gazdar, A. F., Hirsch, F. R., & Minna, J. D. (2015) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.10.009 · Cited by 65
Self-citationImmunotherapy for Small-Cell Lung Cancer: Emerging Evidence
Reck, M., Heigener, D. F., & Reinmuth, N. (2016) · Future Oncology · doi:10.2217/fon-2015-0012 · Cited by 60
Sozzi, G., Huebner, K., & Croce, C. M. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60766-6 · Cited by 59
Chromosomal and genomic changes in lung cancer
Varella‐Garcia, M. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.1.10884 · Cited by 56
NCI series of cell lines: An historical perspective
Gazdar, A. F., & Minna, J. D. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630502 · Cited by 55
Self-citationHistory of Small-Cell Lung Cancer
Haddadin, S., & Perry, M. C. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.03.002 · Cited by 53
Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?
Cristea, S., & Sage, J. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.04.018 · Cited by 52
Wang, Y.-W., Ma, X., Zhang, Y.-A., Wang, M.-J., Yatabe, Y., Lam, S. C., Girard, L., Chen, J.-Y., & Gazdar, A. F. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.010 · Cited by 48
Self-citationNueda, M., Naranjo, A., Baladrón, V., & Laborda, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.07.015 · Cited by 47
Bromodomain and hedgehog pathway targets in small cell lung cancer
Kaur, G., Reinhart, R. A., Monks, A. P., Evans, D., Morris, J., Polley, E. C., & Teicher, B. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.12.001 · Cited by 47
The clinical utility of circulating tumour cells in patients with small cell lung cancer
Foy, V., Fernández‐Gutiérrez, F., Finn, C. F., Dive, C., & Blackhall, F. H. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.07.05 · Cited by 41
New metastatic model of human small‐cell lung cancer by orthotopic transplantation in mice
Sakamoto, S., Inoue, H., Ohba, S., et al. (2015) · Cancer Science · doi:10.1111/cas.12624 · Cited by 36
Vaccine immunotherapy in lung cancer: Clinical experience and future directions
Freeman-Keller, M., Goldman, J. M., & Gray, J. E. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.004 · Cited by 34
Némati, F., Daniel, C., Arvelo, F. A., Legrier, M., Froget, B., Livartowski, A., Assayag, F., Bourgeois, Y., Poupon, M., & Decaudin, D. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283300a29 · Cited by 33
Guo, L., Zhang, T., Xiong, Y., & Yang, Y. (2015) · Disease Markers · doi:10.1155/2015/520590 · Cited by 33
Developing EZH2-Targeted Therapy for Lung Cancer
Frankel, A. E., Liu, X., & Minna, J. D. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0800 · Cited by 32
Self-citationLung cancer-initiating cells: a novel target for cancer therapy
Morrison, B. J., Morris, J. C., & Steel, J. C. (2013) · Targeted Oncology · doi:10.1007/s11523-012-0247-4 · Cited by 31
Notch Signaling in Cancer: Rationale and Strategies for Targeting
Alketbi, A. A., & Attoub, S. (2015) · Current Cancer Drug Targets · doi:10.2174/156800961505150710113353 · Cited by 30
Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma
Ehrlich, D. J., Wang, B., Lü, W., Dowling, P. C., & Yuan, R. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0091-3 · Cited by 30
Antitumor activity of LSD1 inhibitors in lung cancer
Mohammad, H. P., & Kruger, R. G. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1117700 · Cited by 29
Somatostatin Receptors in Lung Cancer: From Function to Molecular Imaging and Therapeutics
Callison, J. C., Walker, R. C., & Massion, P. P. (2011) · Journal of Lung Cancer · doi:10.6058/jlc.2011.10.2.69 · Cited by 25
Awakening of “Schlafen11” to Tackle Chemotherapy Resistance in SCLC
Berns, K., & Berns, A. J. M. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.013 · Cited by 23
Toppling high-grade pulmonary neuroendocrine tumors with a DLL3-targeted trojan horse
Dylla, S. J. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1101515 · Cited by 19
Carney, D. N., Bepler, G., & Gazdar, A. F. (1985) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-82533-0_16 · Cited by 16
Self-citationLázaro, S., Pérez-Crespo, M., Enguita, A. B., Hernández, P., Martínez‐Palacio, J., Oteo, M., Sage, J., Paramio, J. M., & Santos, M. (2016) · Oncotarget · doi:10.18632/oncotarget.13875 · Cited by 15
Functional analysis of lung tumor suppressor activity at 3p21.3
ter Elst, A., Hiemstra, B. E., van der Vlies, P., Kamminga, W., van der Veen, A. Y., Davelaar, I., Terpstra, P., Meerman, G. J. T., Gerbens, F., Kok, K., et al. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20367 · Cited by 11
Current Status of Small Cell Lung Cancer in China
Cheng, Y., Liu, J., Li, H., & Zhang, S. (2014) · Cited by 6
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Rudin, C. M., Poirier, J. T., Byers, L. A., Dive, C., Dowlati, A., George, J., Heymach, J. V., Johnson, J. E., Lehman, J. M., MacPherson, D., et al. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0133-9 · Cited by 1,254
Self-citationNotch signaling pathway: architecture, disease, and therapeutics
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,114
Hellmann, M. D., Callahan, M. K., Awad, M. M., Calvo, E., Ascierto, P. A., Atmaca, A., Rizvi, N. A., Hirsch, F. R., Selvaggi, G., Szustakowski, J. D., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.001 · Cited by 893
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer
Sharma, P., Mehta, M., Dhanjal, D. S., Kaur, S., Gupta, G., Singh, H., Thangavelu, L., Rajeshkumar, S., Tambuwala, M., Bakshi, H. A., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.06.033 · Cited by 430
Metadata
- Authors
- Gazdar, A. F., Bunn, P. A., & Minna, J. D.
- Venue
- Nature Reviews Cancer
- Published
- 2017-12
- Volume
- 17
- Issue
- 12
- Pages
- 725-737
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2765782352
- Cited by
- 904
- References
- 160
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.